ADAMTS4 and chondrosarcoma: Compared with IL-1β-treated human chondrosarcoma cell line SW1353, ADAMTS-4 and ADAMTS-5 expression were decreased dose dependently in the 20 μg/mL CZE and 0.4 μg/mL linarin treatments (Figure 7B).